TickerFactsScreenerDevelopers

Emergent BioSolutions Inc. (EBS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: $40.15M2010: $73.56M2011: $32.10M2012: $29.97M2013: $42.80M2014: $89.19M2015: $141.51M2016: $105.50M2017: $124.30M2018: $89.80M2019: $114.10M2020: $438.50M2021: $341.40M2022: -$170.00M2023: -$726.40M2024: -$108.70M2025: $100.10M$100.10M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$100.10M+192.1%
2024-$108.70M+85.0%
2023-$726.40M-327.3%
2022-$170.00M-149.8%
2021$341.40M-22.1%
2020$438.50M+284.3%
2019$114.10M+27.1%
2018$89.80M-27.8%
2017$124.30M+17.8%
2016$105.50M-25.4%
2015$141.51M+58.7%
2014$89.19M+108.4%
2013$42.80M+42.8%
2012$29.97M-6.6%
2011$32.10M-56.4%
2010$73.56M+83.2%
2009$40.15M—